IBBQ:NSD-Invesco Nasdaq Biotechnology ETF (USD)

ETF | Others |

Last Closing

USD 23.59

Change

-0.11 (-0.46)%

Market Cap

USD 0.04B

Volume

8.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
QQQM Invesco NASDAQ 100 ETF

-1.50 (-0.73%)

USD 34.13B
IBIT iShares Bitcoin Trust

-0.45 (-1.09%)

USD 26.51B
ACWI iShares MSCI ACWI ETF

-0.53 (-0.44%)

USD 19.47B
JEPQ JPMorgan Nasdaq Equity Premium..

-0.18 (-0.32%)

USD 17.54B
CGABL The Carlyle Group Inc. 4.625% ..

-0.03 (-0.15%)

USD 16.14B
NVDL GraniteShares 1.5x Long NVDA D..

-2.06 (-2.67%)

USD 6.01B
TBIL Rbb Fund Inc - Us Treasury 3 M..

N/A

USD 4.33B
USCL iShares Climate Conscious & Tr..

-0.25 (-0.36%)

USD 2.36B
PABU iShares Paris-Aligned Climate ..

-0.15 (-0.23%)

USD 2.10B
IBTF iShares iBonds Dec 2025 Term T..

+0.01 (+0.04%)

USD 2.09B

ETFs Containing IBBQ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 7.77% 61% D- 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 7.77% 61% D- 57% F
Trailing 12 Months  
Capital Gain 25.41% 65% D 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.41% 65% D 58% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -0.20% 43% F 40% F
Dividend Return 0.09% 38% F 36% F
Total Return 0.29% 20% F 9% A-
Risk Return Profile  
Volatility (Standard Deviation) 11.81% 51% F 86% B+
Risk Adjusted Return 0.78% 38% F 36% F
Market Capitalization 0.04B 55% F 25% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.